{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T03:25:33Z","timestamp":1783049133118,"version":"3.54.6"},"reference-count":131,"publisher":"Impact Journals, LLC","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2019,6,11]]},"DOI":"10.18632\/oncotarget.26994","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T18:22:51Z","timestamp":1560277371000},"page":"3952-3977","source":"Crossref","is-referenced-by-count":27,"title":["Emerging therapeutic potential of anti-psychotic drugs in the management of human glioma: A comprehensive review"],"prefix":"10.18632","volume":"10","author":[{"given":"Muhamad N.A.","family":"Kamarudin","sequence":"first","affiliation":[{"name":"Brain Research Institute Monash Sunway (BRIMS), Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishwar","family":"Parhar","sequence":"additional","affiliation":[{"name":"Brain Research Institute Monash Sunway (BRIMS), Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2019,6,11]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Bray","year":"2015","journal-title":"Int J Cancer"},{"key":"2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Jemal","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer Statistics, 2017","volume":"67","author":"Jemal","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3978\/j.issn.2305-5839.2015.03.57","article-title":"Beyond the World Health Organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification","volume":"3","author":"Hadjipanayis","year":"2015","journal-title":"Ann Transl Med"},{"key":"5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Ludwin","year":"2005","journal-title":"N Engl J Med"},{"key":"6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ctrv.2012.05.008","article-title":"Optimal management of elderly patients with glioblastoma","volume":"39","author":"van den Bent","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11060-013-1230-3","article-title":"Glioblastoma management in the temozolomide era: have we improved outcome?","volume":"115","author":"Mason","year":"2013","journal-title":"J Neurooncol"},{"key":"8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Gijtenbeek","year":"2009","journal-title":"Lancet Oncol"},{"key":"9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3322\/caac.21235","article-title":"Cancer treatment and survivorship statistics, 2014","volume":"64","author":"Jemal","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3322\/caac.21349","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Jemal","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.canlet.2014.03.013","article-title":"Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches","volume":"347","author":"Fan","year":"2014","journal-title":"Cancer Lett"},{"key":"12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nrd4201","article-title":"Targeting tumour-supportive cellular machineries in anticancer drug development","volume":"13","author":"Moll","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2174\/1874467211205010102","article-title":"Temozolomide: mechanisms of action, repair and resistance","volume":"5","author":"Bradshaw","year":"2012","journal-title":"Curr Mol Pharmacol"},{"key":"14","doi-asserted-by":"publisher","first-page":"v167","DOI":"10.1093\/neuonc\/nou265.40","article-title":"NT-40 Interim analysis of the EF-14 trial: a prospective, multi-center trial of NovoTTF-100A together with temozolomide compared to temozolomide alone in patients with newly diagnosed GBM","volume":"16","author":"Ram","year":"2014","journal-title":"Neuro Oncol"},{"key":"15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S1470-2045(01)00456-9","article-title":"Depression in cancer patients","volume":"2","author":"Chochinov","year":"2001","journal-title":"Lancet Oncol"},{"key":"16","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1634\/theoncologist.2009-0122","article-title":"The assessment and management of delirium in cancer patients","volume":"14","author":"Bruera","year":"2009","journal-title":"Oncologist"},{"key":"17","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/sj.mp.4000581","article-title":"Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia","volume":"4","author":"Lieberman","year":"1999","journal-title":"Mol Psychiatry"},{"key":"18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev-med-050911-161504","article-title":"Update on typical and atypical antipsychotic drugs","volume":"64","author":"Meltzer","year":"2013","journal-title":"Annu Rev Med"},{"key":"19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/070674370204700106","article-title":"Atypical antipsychotics: mechanism of action","volume":"47","author":"Seeman","year":"2002","journal-title":"Can J Psychiatry"},{"key":"20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2165\/00023210-200620050-00004","article-title":"Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia","volume":"20","author":"H\u00f6schl","year":"2006","journal-title":"CNS Drugs"},{"key":"21","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S0140-6736(14)61231-9","article-title":"Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial","volume":"384","author":"Murray","year":"2014","journal-title":"Lancet"},{"key":"22","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1016\/j.ejca.2009.07.011","article-title":"Screening of anti-glioma effects induced by sigma-1 receptor ligands: potential new use for old anti-psychiatric medicines","volume":"45","author":"Kiss","year":"2009","journal-title":"Eur J Cancer"},{"key":"23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2014.11.012","article-title":"Haloperidol metabolite II prodrug: asymmetric synthesis and biological evaluation on rat C6 glioma cells","volume":"90","author":"Marrazzo","year":"2015","journal-title":"Eur J Med Chem"},{"key":"24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1385\/JMN:22:3:189","article-title":"Characterization of phenothiazine-induced apoptosis in neuroblastoma and glioma cell lines: clinical relevance and possible application for brain-derived tumors","volume":"22","author":"Weizman","year":"2004","journal-title":"J Mol Neurosci"},{"key":"25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1691\/ph.2018.7806","article-title":"Perphenazine and prochlorperazine induce concentration-dependent loss in human glioblastoma cells viability","volume":"73","author":"Buszman","year":"2018","journal-title":"Pharmazie"},{"key":"26","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3892\/ijo_00000756","article-title":"novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells","volume":"37","author":"Nordenberg","year":"2010","journal-title":"Int J Oncol"},{"key":"27","doi-asserted-by":"publisher","first-page":"e1753","DOI":"10.1038\/cddis.2015.77","article-title":"Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data","volume":"6","author":"Huang","year":"2015","journal-title":"Cell Death Dis"},{"key":"28","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/gt.2015.72","article-title":"screening of clinical drugs identifies sensitizers of oncolytic viral therapy in glioblastoma stem-like cells","volume":"22","author":"Lamfers","year":"2015","journal-title":"Gene Ther"},{"key":"29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1158\/1535-7163.MCT-16-0169-T","article-title":"Trifluoperazine, a Well-known Antipsychotic, Inhibits Glioblastoma Invasion by Binding to Calmodulin, and Disinhibiting Calcium Release Channel IP3R","volume":"16","author":"Lee","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"30","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ejmech.2018.03.055","article-title":"Repositioning of the antipsychotic trifluoperazine: Synthesis, biological evaluation andstudy of trifluoperazine analogs as anti-glioblastoma agents","volume":"151","author":"Roh","year":"2018","journal-title":"Eur J Med Chem"},{"key":"31","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13046-017-0588-z","article-title":"Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination","volume":"36","author":"Li","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"key":"32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/02688699409027965","article-title":"Chlorpromazine in combination with nitrosourea inhibits experimental glioma growth","volume":"8","author":"Salford","year":"1994","journal-title":"Br J Neurosurg"},{"key":"33","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1093\/carcin\/bgt169","article-title":"The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt\/mTOR pathway in human U-87MG glioma cells","volume":"34","author":"Lee","year":"2013","journal-title":"Carcinogenesis"},{"key":"34","doi-asserted-by":"publisher","first-page":"37568","DOI":"10.18632\/oncotarget.17247","article-title":"Repositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit","volume":"8","author":"Griguer","year":"2017","journal-title":"Oncotarget"},{"key":"35","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/j.cellsig.2006.02.004","article-title":"Clozapine, a neuroleptic agent, inhibits Akt by counteracting Ca2+\/calmodulin in PTEN-negative U-87MG human glioblastoma cells","volume":"18","author":"Lee","year":"2006","journal-title":"Cell Signal"},{"key":"36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11060-014-1688-7","article-title":"Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide\u2019s antiproliferative effect","volume":"122","author":"Halatsch","year":"2015","journal-title":"J Neurooncol"},{"key":"37","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00280-017-3329-2","article-title":"Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme","volume":"79","author":"Obuchowicz","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"key":"38","doi-asserted-by":"publisher","first-page":"37511","DOI":"10.18632\/oncotarget.16400","article-title":"Promoting oligodendroglial-oriented differentiation of glioma stem cell: a repurposing of quetiapine for the treatment of malignant glioma","volume":"8","author":"Xiao","year":"2017","journal-title":"Oncotarget"},{"key":"39","doi-asserted-by":"publisher","first-page":"60727","DOI":"10.18632\/oncotarget.18337","article-title":"Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen","volume":"8","author":"Halatsch","year":"2017","journal-title":"Oncotarget"},{"key":"40","first-page":"161","article-title":"Estimation of apoptosis in C6 glioma cells treated with antidepressants","volume":"46","author":"Rittich","year":"1997","journal-title":"Physiol Res"},{"key":"41","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1385\/JMN:27:1:029","article-title":"Differential induction of apoptosis by antidepressants in glioma and neuroblastoma cell lines: evidence for p-c-Jun, cytochrome c, and caspase-3 involvement","volume":"27","author":"Weizman","year":"2005","journal-title":"J Mol Neurosci"},{"key":"42","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1093\/neuonc\/not111","article-title":"Comparative drug pair screening across multiple glioblastoma cell lines reveals novel drug-drug interactions","volume":"15","author":"Karlsson-Lindahl","year":"2013","journal-title":"Neuro Oncol"},{"key":"43","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.18632\/oncotarget.3243","article-title":"Fluoxetine, an antidepressant, suppresses glioblastoma by evoking AMPAR-mediated calcium-dependent apoptosis","volume":"6","author":"Shen","year":"2015","journal-title":"Oncotarget"},{"key":"44","doi-asserted-by":"publisher","first-page":"23372","DOI":"10.1038\/srep23372","article-title":"Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerization","volume":"6","author":"Tomizawa","year":"2016","journal-title":"Sci Rep"},{"key":"45","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/(SICI)1099-0461(1999)13:6<338::AID-JBT8>3.0.CO;2-7","article-title":"The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activation","volume":"13","author":"N\u00e4ssberger","year":"1999","journal-title":"J Biochem Mol Toxicol"},{"key":"46","doi-asserted-by":"publisher","first-page":"e1203","DOI":"10.1038\/cddis.2014.113","article-title":"High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy","volume":"5","author":"Melino","year":"2014","journal-title":"Cell Death Dis"},{"key":"47","doi-asserted-by":"publisher","first-page":"16926","DOI":"10.18632\/oncotarget.4700","article-title":"Anti-tumoral effect of desmethylclomipramine in lung cancer stem cells","volume":"6","author":"Melino","year":"2015","journal-title":"Oncotarget"},{"key":"48","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/978-94-007-0344-5_26","volume-title":"Tumors of the Central Nervous System, Volume 1. Tumors of the Central Nervous System","volume":"vol 1","author":"Hayat","year":"2011"},{"key":"49","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.bbrc.2005.01.028","article-title":"Chlorimipramine: a novel anticancer agent with a mitochondrial target","volume":"328","author":"Bates","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"50","first-page":"87","article-title":"Apoptosis of human malignant glioma-derived cell cultures treated with clomipramine hydrochloride, as detected by Annexin-V assay","volume":"40","author":"Pilkington","year":"2006","journal-title":"Radiol Oncol"},{"key":"51","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3892\/ijo.32.4.829","article-title":"Potentiation of cytotoxicity by combination of imatinib and chlorimipramine in glioma","volume":"32","author":"Bonavida","year":"2008","journal-title":"Int J Oncol"},{"key":"52","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11060-010-0209-6","article-title":"Enhancement of vinorelbine-induced cytotoxicity and apoptosis by clomipramine and lithium chloride in human neuroblastoma cancer cell line SH-SY5Y","volume":"100","author":"Sabanci","year":"2010","journal-title":"J Neurooncol"},{"key":"53","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.bbrc.2011.08.093","article-title":"The tricyclic antidepressant imipramine induces autophagic cell death in U-87MG glioma cells","volume":"413","author":"Shin","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"54","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1586\/14737175.2014.947965","article-title":"Lithium for bipolar disorder: a review of the recent literature","volume":"14","author":"Ravindran","year":"2014","journal-title":"Expert Rev Neurother"},{"key":"55","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s40263-016-0380-1","article-title":"Therapeutic mechanisms of lithium in bipolar disorder: recent advances and current understanding","volume":"30","author":"Outhred","year":"2016","journal-title":"CNS Drugs"},{"key":"56","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ejphar.2014.06.042","article-title":"Lithium: a review of pharmacology, clinical uses, and toxicity","volume":"740","author":"Lund","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"57","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/FBP.0b013e32833da5da","article-title":"Intracellular pathways underlying the effects of lithium","volume":"21","author":"Fornai","year":"2010","journal-title":"Behav Pharmacol"},{"key":"58","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/mp.2015.4","article-title":"Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics","volume":"20","author":"Alda","year":"2015","journal-title":"Mol Psychiatry"},{"key":"59","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1215\/15228517-2008-041","article-title":"Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3","volume":"10","author":"Lawler","year":"2008","journal-title":"Neuro Oncol"},{"key":"60","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/stem.1035","article-title":"Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences","volume":"30","author":"Saleem","year":"2012","journal-title":"Stem Cells"},{"key":"61","doi-asserted-by":"publisher","first-page":"9090","DOI":"10.1158\/0008-5472.CAN-09-2552","article-title":"MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer","volume":"69","author":"Mukherjee","year":"2009","journal-title":"Cancer Res"},{"key":"62","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1476-4598-10-10","article-title":"Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer","volume":"10","author":"Zeng","year":"2011","journal-title":"Mol Cancer"},{"key":"63","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/16476","article-title":"The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus","volume":"397","author":"van Lohuizen","year":"1999","journal-title":"Nature"},{"key":"64","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1054\/bjoc.2001.1791","article-title":"The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression","volume":"84","author":"Betticher","year":"2001","journal-title":"Br J Cancer"},{"key":"65","doi-asserted-by":"publisher","first-page":"e7443","DOI":"10.1371\/journal.pone.0007443","article-title":"GSK3\u03b2 regulates differentiation and growth arrest in glioblastoma","volume":"4","author":"Lino","year":"2009","journal-title":"PLoS One"},{"key":"66","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Reardon","year":"2009","journal-title":"N Engl J Med"},{"key":"67","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1007\/s11033-014-3258-7","article-title":"Lithium chloride decreases proliferation and migration of C6 glioma cells harboring isocitrate dehydrogenase 2 mutant via GSK-3\u03b2","volume":"41","author":"Hu","year":"2014","journal-title":"Mol Biol Rep"},{"key":"68","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1179\/1743132813Y.0000000283","article-title":"Sorafenib and lithium chloride combination treatment shows promising synergistic effects in human glioblastoma multiforme cellsbut midkine is not implicated","volume":"36","author":"Bilir","year":"2014","journal-title":"Neurol Res"},{"key":"69","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1080\/01616412.2016.1203096","article-title":"Antagonist activity of the antipsychotic drug lithium chloride and the antileukemic drug imatinib mesylate during glioblastoma treatment","volume":"38","author":"Bilir","year":"2016","journal-title":"Neurol Res"},{"key":"70","doi-asserted-by":"publisher","first-page":"22811","DOI":"10.18632\/oncotarget.15206","article-title":"Biological basis and clinical study of glycogen synthase kinase- 3\u03b2-targeted therapy by drug repositioning for glioblastoma","volume":"8","author":"Nakada","year":"2017","journal-title":"Oncotarget"},{"key":"71","first-page":"3585","article-title":"Valproic acid inhibits proliferation and changes expression of CD44 and CD56 of malignant glioma cells","volume":"18","author":"Cinatl","year":"1998","journal-title":"Anticancer Res"},{"key":"72","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1046\/j.1471-4159.2002.01081.x","article-title":"Antiproliferative action of valproate is associated with aberrant expression and nuclear translocation of cyclin D3 during the C6 glioma G1 phase","volume":"83","author":"Regan","year":"2002","journal-title":"J Neurochem"},{"key":"73","doi-asserted-by":"publisher","first-page":"14666","DOI":"10.18632\/oncotarget.14716","article-title":"Valproic acid inhibits glioblastoma multiforme cell growth via paraoxonase 2 expression","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"74","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/neuonc\/nop005","article-title":"Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines","volume":"12","author":"Chen","year":"2010","journal-title":"Neuro Oncol"},{"key":"75","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2176\/nmc.52.186","article-title":"Valproic acid inhibits angiogenesisand glioma angiogenesisin the brain","volume":"52","author":"Matsumura","year":"2012","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"76","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11060-007-9402-7","article-title":"Valproic acid induces p21 and topoisomerase-II (\u03b1\/\u03b2) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines","volume":"85","author":"Gopalakrishnan","year":"2007","journal-title":"J Neurooncol"},{"key":"77","first-page":"535","article-title":"Epigenetic modifiers as anticancer drugs: effectiveness of valproic acid in neural crest-derived tumor cells","volume":"30","author":"Orlandi","year":"2010","journal-title":"Anticancer Res"},{"key":"78","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.neuroscience.2008.07.065","article-title":"Valproic acid induces polarization, neuronal-like differentiation of a subpopulation of C6 glioma cells and selectively regulates transgene expression","volume":"156","author":"Segovia","year":"2008","journal-title":"Neuroscience"},{"key":"79","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.toxrep.2014.05.005","article-title":"anticancer drug test: A new method emerges from the model of glioma stem cells","volume":"1","author":"Bentivegna","year":"2014","journal-title":"Toxicol Rep"},{"key":"80","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.3892\/or.2016.4665","article-title":"Epigenetic targeting of glioma stem cells: short-term and long-term treatments with valproic acid modulate DNA methylation and differentiation behavior, but not temozolomide sensitivity","volume":"35","author":"Bentivegna","year":"2016","journal-title":"Oncol Rep"},{"key":"81","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/sj.bjp.0707608","article-title":"Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells","volume":"153","author":"Canonico","year":"2008","journal-title":"Br J Pharmacol"},{"key":"82","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3727\/096504007783338340","article-title":"Valproic acid increases theeffects of nitrosureas on human glioma cell lines","volume":"16","author":"Croci","year":"2007","journal-title":"Oncol Res"},{"key":"83","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1007\/s11064-011-0554-7","article-title":"Valproic acid induced differentiation and potentiated efficacy of taxol and nanotaxol for controlling growth of human glioblastoma LN18 and T98G cells","volume":"36","author":"Ray","year":"2011","journal-title":"Neurochem Res"},{"key":"84","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00109-010-0707-1","article-title":"Enhancement of temozolomide-induced apoptosis by valproic acid in human glioma cell lines through redox regulation","volume":"89","author":"Yang","year":"2011","journal-title":"J Mol Med (Berl)"},{"key":"85","first-page":"899","article-title":"Adaptive Immune Response to and Survival Effect of Temozolomide- and Valproic Acid-induced Autophagy in Glioblastoma","volume":"36","author":"Uhl","year":"2016","journal-title":"Anticancer Res"},{"key":"86","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.canlet.2014.09.049","article-title":"DNA damage response and anti-apoptotic proteins predict radiosensitization efficacy of HDAC inhibitors SAHA and LBH589 in patient-derived glioblastoma cells","volume":"356","author":"Leenstra","year":"2015","journal-title":"Cancer Lett"},{"key":"87","first-page":"4338","article-title":"Histone deacetylase inhibitor, 2-propylpentanoic acid, increases the chemosensitivity and radiosensitivity of human glioma cell lines","volume":"125","author":"Chen","year":"2012","journal-title":"Chin Med J (Engl)"},{"key":"88","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3892\/ol.2013.1666","article-title":"Histone deacetylase inhibitor, valproic acid, radiosensitizes the C6 glioma cell line","volume":"7","author":"Jiang","year":"2014","journal-title":"Oncol Lett"},{"key":"89","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/ijc.20774","article-title":"Enhancement ofandtumor cell radiosensitivity by valproic acid","volume":"114","author":"Tofilon","year":"2005","journal-title":"Int J Cancer"},{"key":"90","doi-asserted-by":"publisher","first-page":"5410","DOI":"10.1158\/1078-0432.CCR-08-0643","article-title":"Postradiation sensitization of the histone deacetylase inhibitor valproic acid","volume":"14","author":"Tofilon","year":"2008","journal-title":"Clin Cancer Res"},{"key":"91","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11060-011-0725-z","article-title":"Valproic acid sensitizes human glioma cells for temozolomide and \u03b3-radiation","volume":"107","author":"Stalpers","year":"2012","journal-title":"J Neurooncol"},{"key":"92","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s11060-014-1713-x","article-title":"The effect of valproic acid in combination with irradiation and temozolomide on primary human glioblastoma cells","volume":"122","author":"Martin","year":"2015","journal-title":"J Neurooncol"},{"key":"93","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1748-717X-9-89","article-title":"Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines","volume":"9","author":"Gaipl","year":"2014","journal-title":"Radiat Oncol"},{"key":"94","doi-asserted-by":"publisher","first-page":"35004","DOI":"10.18632\/oncotarget.5253","article-title":"Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells","volume":"6","author":"Hallahan","year":"2015","journal-title":"Oncotarget"},{"key":"95","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1517\/13543780903485642","article-title":"Targeting cancer with phosphodiesterase inhibitors","volume":"19","author":"Schermuly","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"key":"96","first-page":"589","article-title":"Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia","volume":"8","author":"Lerner","year":"2002","journal-title":"Clin Cancer Res"},{"key":"97","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.tips.2011.02.015","article-title":"Treating brain tumors with PDE4 inhibitors","volume":"32","author":"Rubin","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"98","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.lfs.2011.12.010","article-title":"Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1\/Rap1 pathways","volume":"90","author":"Lee","year":"2012","journal-title":"Life Sci"},{"key":"99","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.lfs.2017.02.005","article-title":"Rolipram potentiates bevacizumab-induced cell death in human glioblastoma stem-like cells","volume":"173","author":"Joghataei","year":"2017","journal-title":"Life Sci"},{"key":"100","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/JCP.0000000000000331","article-title":"Exacerbation of tics after combining aripiprazole with pimozide: a case with Tourette Syndrome","volume":"35","author":"\u00d6ztop","year":"2015","journal-title":"J Clin Psychopharmacol"},{"key":"101","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S0190-9622(08)80767-0","article-title":"Pimozide in delusions of parasitosis","volume":"22","author":"Pierce","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"102","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1176\/appi.ajp.162.2.377","article-title":"Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder","volume":"162","author":"Phillips","year":"2005","journal-title":"Am J Psychiatry"},{"key":"103","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.neubiorev.2015.12.013","article-title":"Interventions for tic disorders: an overview of systematic reviews and meta analyses","volume":"63","author":"Zhang","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"104","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.critrevonc.2018.06.004","article-title":"Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastoma","volume":"128","author":"Altinoz","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"105","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3892\/ijo.2015.3229","article-title":"The antipsychotic drug pimozide inhibits cell growth in prostate cancer through suppression of STAT3 activation","volume":"48","author":"Chen","year":"2016","journal-title":"Int J Oncol"},{"key":"106","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1053\/j.gastro.2016.08.040","article-title":"Expression of DRD2 is increased in human pancreatic ductal adenocarcinoma and inhibitors slow tumor growth in mice","volume":"151","author":"Sipos","year":"2016","journal-title":"Gastroenterology"},{"key":"107","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.lfs.2018.08.027","article-title":"Pimozide suppresses colorectal cancer via inhibition of Wnt\/\u03b2-catenin signaling pathway","volume":"209","author":"Tang","year":"2018","journal-title":"Life Sci"},{"key":"108","doi-asserted-by":"publisher","first-page":"768","DOI":"10.7150\/ijbs.14718","article-title":"Inhibition of wnt\/\u03b2-catenin Signaling in Hepatocellular Carcinoma by an Antipsychotic Drug Pimozide","volume":"12","author":"Wang","year":"2016","journal-title":"Int J Biol Sci"},{"key":"109","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1476-4598-12-91","article-title":"USP1 deubiquitinase: cellular functions, regulatory mechanisms and emerging potential as target in cancer therapy","volume":"12","author":"Rodr\u00edguez","year":"2013","journal-title":"Mol Cancer"},{"key":"110","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1023\/A:1006046604062","article-title":"The cell death response to \u03b3-radiation in MCF-7 cells is enhanced by a neuroleptic drug, pimozide","volume":"51","author":"Hylton","year":"1998","journal-title":"Breast Cancer Res Treat"},{"key":"111","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0024-3205(85)90120-1","article-title":"Inhibition of growth of C6 astrocytoma cells by inhibitors of calmodulin","volume":"36","author":"Hait","year":"1985","journal-title":"Life Sci"},{"key":"112","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0922-4106(93)90029-9","article-title":"Sigma receptor-active neuroleptics are cytotoxic to C6 glioma cells in culture","volume":"244","author":"Bowen","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"113","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/neuonc\/nov091","article-title":"USP1 targeting impedes GBM growth by inhibiting stem cell maintenance and radioresistance","volume":"18","author":"Lee","year":"2016","journal-title":"Neuro Oncol"},{"key":"114","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/COC.0b013e3181e8461a","article-title":"Selective serotonin reuptake inhibitors, glioblastoma multiforme, and impact on toxicities and overall survival: the mayo clinic experience","volume":"34","author":"Rummans","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"115","first-page":"2437","article-title":"Influence of valproic acid on outcome of high-grade gliomas in children","volume":"28","author":"Wolff","year":"2008","journal-title":"Anticancer Res"},{"key":"116","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ijrobp.2015.04.038","article-title":"A phase 2 study of concurrent radiation therapy, temozolomide, and the histone deacetylase inhibitor valproic acid for patients with glioblastoma","volume":"92","author":"Camphausen","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"117","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11060-008-9662-x","article-title":"Valproic acid was well tolerated in heavily pretreated pediatric patients with high-grade glioma","volume":"90","author":"Driever","year":"2008","journal-title":"J Neurooncol"},{"key":"118","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3109\/02688697.2011.638996","article-title":"Effect of valproic acid on the outcome of glioblastoma multiforme","volume":"26","author":"Lee","year":"2012","journal-title":"Br J Neurosurg"},{"key":"119","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/pbc.20083","article-title":"Valproic acid treatment of glioblastoma multiforme in a child","volume":"43","author":"Pekrun","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"120","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/MPH.0b013e3181d74702","article-title":"Sorafenib plus valproic acid for infant spinal glioblastoma","volume":"32","author":"Wolff","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"121","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1158\/1078-0432.CCR-10-0738","article-title":"Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children\u2019s oncology group report","volume":"17","author":"Blaney","year":"2011","journal-title":"Clin Cancer Res"},{"key":"122","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1212\/WNL.0b013e31822f02e1","article-title":"Prolonged survival with valproic acid use in the EORTC\/NCIC temozolomide trial for glioblastoma","volume":"77","author":"Mirimanoff","year":"2011","journal-title":"Neurology"},{"key":"123","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11060-004-2338-2","article-title":"P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy","volume":"72","author":"Grisold","year":"2005","journal-title":"J Neurooncol"},{"key":"124","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ijrobp.2013.02.012","article-title":"Valproic acid use during radiation therapy for glioblastoma associated with improved survival","volume":"86","author":"Chan","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"125","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.seizure.2014.06.015","article-title":"Survival analysis for valproic acid use in adult glioblastoma multiforme: a meta-analysis of individual patient data and a systematic review","volume":"23","author":"Yunhe","year":"2014","journal-title":"Seizure"},{"key":"126","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/neuonc\/not057","article-title":"Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme","volume":"15","author":"Vecht","year":"2013","journal-title":"Neuro Oncol"},{"key":"127","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s11060-016-2054-8","article-title":"Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II\/III gliomas treated with temozolomide","volume":"127","author":"Nahed","year":"2016","journal-title":"J Neurooncol"},{"key":"128","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/s41598-018-19413-y","article-title":"Low concentration trifluoperazine promotes proliferation and reduces calcium-dependent apoptosis in glioma cells","volume":"8","author":"Liu","year":"2018","journal-title":"Sci Rep"},{"key":"129","doi-asserted-by":"publisher","first-page":"205","DOI":"10.21307\/ane-2017-054","article-title":"The differential effects of neuroleptic drugs and PACAP on the expression of BDNF mRNA and protein in a human glioblastoma cell line","volume":"77","author":"Kowalczyk","year":"2017","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"130","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s00415-009-5156-9","article-title":"Efficacy of anti-epileptic drugs in patients with gliomas and seizures","volume":"256","author":"Vecht","year":"2009","journal-title":"J Neurol"},{"key":"131","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1200\/JCO.2015.63.6563","article-title":"Does valproic acid or levetiracetam improve survival in glioblastoma? A pooled analysis of prospective clinical trials in newly diagnosed glioblastoma","volume":"34","author":"Mehta","year":"2016","journal-title":"J Clin Oncol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.26994","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T11:48:31Z","timestamp":1588852111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.26994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,11]]},"references-count":131,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2019,6,11]]}},"alternative-id":["26994","31231472"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.26994","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,11]]}}}